|
|
NIH and the research community are facing a myriad of changes and challenges. It is critical for those who hope for NIH funding to be current and knowledgeable, for the benefit of themselves and the individuals they mentor. Researchers in child language ARE being funded and NIH maintains an ongoing commitment to supporting that research. This presentation will address topics of importance to new as well as more senior researchers. Some of the issues we will address include the following:
Recent changes at the NIH
New investigator opportunities
New NIH priorities
The funding “picture”
Highlights re: submission, review and funding
Recent NIDCD trends in child language
A special focus of this session will be the NIDCD clinical trials program: NIDCD is committed to building and expanding its clinical trials program to promote the development of interventions. Three new clinical trial initiatives and funding opportunities will be discussed, in particular, Phase I/II Preliminary Clinical Trials specifically targeting studies that will provide preliminary data and optimize the design of the eventual phase III trial; Phase III Clinical Trial Planning Grants; and, Definitive Clinical Trials. NIDCD’s encouragement and support of clinical trial research will be discussed.
|
|
|
|
|
Dr. Judith A. Cooper is currently Deputy Director of the National
Institute on Deafness and Other Communication Disorders at the NIH. In
addition, she serves as Director, Division of Scientific Programs,
within NIDCD, and finally, she has programmatic responsibilities for
the areas of language, language impairments, and language in deaf
individuals. She received her B.F.A. at Southern Methodist University
in 1971 with a major in Speech-Language Pathology, her M.S. in
Speech-Language Pathology at Vanderbilt University in 1972, and her
Ph.D. at the University of Washington in 1982 in Speech and Hearing
Sciences. She was elected a Fellow of the American
Speech-Language-Hearing Association in 2006 and received the Honors of
the Association in 2007.
She joined the National Institutes of Health as a Health Scientist
Administrator (HSA) within the National Institute of Neurological and
Communicative Disorders and Stroke in November, 1982. Dr. Cooper became
an HSA within the National Institute on Deafness and Other Communication
Disorders, upon its establishment in October, 1988; subsequently served
as Deputy Director as well as acting director of the Division of Human
Communication; Chief, Scientific Programs Branch; and has been in her
current position since January, 2004.
Dr. Cooper's current responsibilities include overseeing and
coordinating the activities of her division; advising within NIDCD
and across the NIH regarding issues related to language and language
disorders; participating in trans-NIH initiatives focused in language
as well as autism; and, working with potential and funded researchers
in language across the US and beyond, providing advice, direction, and
encouragement related to research grant focus, development and
preparation.
|
|
Gordon B. Hughes is Program Officer for clinical trials at the National Institute on Deafness and Other Communication Disorders at the National Institutes of Health. He arrived at the NIDCD in July, 2008 to begin a second career, having performed surgery of the ear and related disorders at the Cleveland Clinic in Ohio for 28 years. Dr, Hughes completed an A.B. degree at Dartmouth College in 1970, an M.D. degree at Case Western Reserve University School of Medicine in 1974, residency in otolaryngology-head and neck surgery at Cleveland Clinic in 1979 and fellowship in skull base surgery in Nashville in 1980. In 1980 he joined the professional staff of the Cleveland Clinic in otology-neurotology at the Head and Neck Institute. He was appointed director of resident education from 1983-2001 and professor of otolaryngology in 1999. He is a diplomat of the American Board of Otolaryngology and is licensed to practice otolaryngology (ENT) in Maryland. In coming to NIDCD, Dr. Hughes retired from patient care and from research in T-cell mechanisms of autoimmune sensorineural hearing loss for which he was awarded a patent in 2007. He remains an active member of various academic societies related to his work at NIDCD. He is author-editor of 3 editions of Clinical Otology published by Thieme Publishers, New York, of which the third edition was awarded runner-up best otolaryngology book worldwide in 2007 by the British Medical Society. He has authored hundreds of chapters, articles, editorials, exhibits and posters. Dr. Hughes is committed to building and expanding the NIDCD clinical trials program to promote the development of interventions to treat or prevent disorders in hearing, balance, taste, smell, voice, speech and language.
|
|
|